5//SEC Filing
PRINS RICHARD K 5
Accession 0001185185-25-000496
CIK 0001326205other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:11 PM ET
Size
14.9 KB
Accession
0001185185-25-000496
Insider Transaction Report
Form 5
PRINS RICHARD K
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+58,333→ 1,101,251 total - Exercise/Conversion
Common Stock
2025-03-31+100,000→ 1,201,251 total - Exercise/Conversion
Common Stock
2025-03-31+70,000→ 1,271,251 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−58,333→ 0 total→ Common Stock (58,333 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-31−100,000→ 100,000 total→ Common Stock (100,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-31−70,000→ 140,000 total→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.
- [F2]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
- [F3]On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.
- [F4]Each restricted stock unit represents a right to receive one share of IGC common stock.
Documents
Issuer
IGC Pharma, Inc.
CIK 0001326205
Entity typeother
Related Parties
1- filerCIK 0001047579
Filing Metadata
- Form type
- 5
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:11 PM ET
- Size
- 14.9 KB